(XERS) Xeris Pharmaceuticals - Performance 178.9% in 12m
Compare XERS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
22.88%
#38 in Group
Rel. Strength
97.78%
#178 in Universe
Total Return 12m
178.92%
#9 in Group
Total Return 5y
45.76%
#24 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -4.19%
23th Percentile in Group
12m Total Return: XERS (178.9%) vs XLV (-4.1%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: XERS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for XERS
Total Return (including Dividends) | XERS | XLV | S&P 500 |
---|---|---|---|
1 Month | 24.94% | 0.87% | 13.81% |
3 Months | 44.54% | -7.96% | -6.30% |
12 Months | 178.92% | -4.06% | 10.65% |
5 Years | 45.76% | 43.49% | 107.77% |
Trend Score (consistency of price movement) | XERS | XLV | S&P 500 |
1 Month | 72.1% | -8.1% | 83% |
3 Months | 49.9% | -75.3% | -75.3% |
12 Months | 97.2% | -28.8% | 50.1% |
5 Years | -26.7% | 89.7% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #150 | 23.9% | 9.78% |
3 Month | #14 | 57.0% | 54.3% |
12 Month | #10 | 191% | 152% |
5 Years | #23 | 1.58% | -29.9% |
FAQs
Does XERS Xeris Pharmaceuticals outperforms the market?
Yes,
over the last 12 months XERS made 178.92%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months XERS made 44.54%, while XLV made -7.96%.
Over the last 3 months XERS made 44.54%, while XLV made -7.96%.
Performance Comparison XERS vs Indeces and Sectors
XERS vs. Indices XERS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 14.0% | 11.1% | 53.6% | 168% |
US NASDAQ 100 | QQQ | 13.8% | 7.58% | 53.4% | 167% |
US Dow Jones Industrial 30 | DIA | 13.6% | 15.0% | 53.9% | 171% |
German DAX 40 | DAX | 14.0% | 9.98% | 27.4% | 153% |
Shanghai Shenzhen CSI 300 | CSI 300 | 11.8% | 13.1% | 52.9% | 172% |
Hongkong Hang Seng | HSI | 10.8% | 5.01% | 45.3% | 165% |
India NIFTY 50 | INDA | 18.9% | 20.1% | 53.2% | 179% |
Brasil Bovespa | EWZ | 13.0% | 7.70% | 44.9% | 187% |
XERS vs. Sectors XERS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 13.4% | 11.5% | 46.6% | 157% |
Consumer Discretionary | XLY | 13.6% | 10.7% | 54.6% | 165% |
Consumer Staples | XLP | 14.9% | 18.4% | 46.7% | 170% |
Energy | XLE | 14.2% | 18.2% | 60.2% | 188% |
Financial | XLF | 12.9% | 11.4% | 46.5% | 156% |
Health Care | XLV | 17.0% | 24.1% | 58.6% | 183% |
Industrial | XLI | 12.3% | 8.12% | 52.2% | 168% |
Materials | XLB | 14.2% | 11.4% | 58.5% | 184% |
Real Estate | XLRE | 15.3% | 13.4% | 52.9% | 163% |
Technology | XLK | 12.9% | 3.72% | 56.5% | 172% |
Utilities | XLU | 14.0% | 15.4% | 46.0% | 161% |
Aerospace & Defense | XAR | 12.0% | 3.78% | 42.1% | 152% |
Biotech | XBI | 20.6% | 13.1% | 73.8% | 191% |
Homebuilder | XHB | 13.5% | 13.5% | 66.8% | 186% |
Retail | XRT | 12.1% | 10.3% | 57.9% | 180% |